Egyptian Drug Market Facing Challenges

Egypt's pharmaceutical market was worth EGP11.5bn (US$1.94bn) in 2005 and is one of the largest in the Eastern Mediterranean region, second only to Turkey. However, government cost containment measures and the rising cost of raw materials has placed significant pressure on profit margins in recent years. Moreover, issues pertaining to intellectual property, and especially the lack of an effective data exclusivity and patent linkage system, continue to have a restrictive effect on market

To read the full article, please sign in or take a free trial.